The Chickenpox Vaccine, also known as the Varicella Vaccine, is a highly effective way to prevent Chickenpox. The vaccine contains a weakened form of the virus that helps the body develop immunity to the disease without causing illness.Imagine a world where vaccines can travel to the most remote parts of the world unfettered by temperature restrictions. This revolutionary vision is becoming a reality thanks to the development of thermostable vaccines.
These trailblazing vaccines hold the potential to:
These trailblazing vaccines hold the potential to:
- Save millions of lives: By eliminating the need for cold storage chains, thermal vaccines can expand access to life-saving vaccines in areas of limited or unreliable resources.
- Increase affordability: The complex cold chain requirements for traditional vaccines tend to drive up prices and limit distribution channels. thermostable vaccines can be stored and transported at room temperature, greatly reducing logistical complexity and costs.
- Enhance disease prevention: Because of widespread infection and ease of transmission, thermostable vaccines can prevent preventable diseases affecting developing countries improperly.
- Here’s why thermostable vaccines are such a breakthrough: They are stable at high temperatures: unlike traditional vaccines that require strict refrigeration (2-8°C), thermal vaccines can withstand heat transfer at higher size edge, typically 25°C to 40°C, longer This eliminates the need for expensive cold chain equipment and opens up new delivery options.
- They work just as well: Extensive research has shown that thermostable vaccines retain potency and immunity even at high temperatures, preventing disease.
- Thermostable technology is being explored for various vaccines including those targeting polio, rotavirus, measles, and even COVID-19.
- The promise of thermostable vaccines is bringing hope to the future of global health. These groundbreaking innovations have the potential to close the gap in vaccine access and immunize millions more individuals, ultimately leading to a healthier and more equitable world.
How Does It Work?
- The Chickenpox Vaccine contains a weakened form of the varicella virus, which stimulates the immune system to produce antibodies that can protect against future infections.
Who Should Get the Vaccine?
- The Centers for Disease Control and Prevention (CDC) recommends two doses of the Chickenpox Vaccine for children, adolescents, and adults who have never been infected with Chickenpox before or were not vaccinated. Children are routinely recommended to receive the first dose at 12 through 15 months of age and the second dose at 4 through 6 years of age.
What makes NEXIPOX® Advance PFS A Superior Varicella Vaccine?
- World’s only Thermostable Varicella Vaccine which can endure Indian climatic changes.
- Fortified with Trehalose providing exceptional stability, and ensuring superior efficacy
- NEXIPOX® has a 0% Breakthrough Rate after two doses
- Nearly 100% Antigenic Delivery ensuring 100% protection from the Chickenpox Virus
- Approved for 2 Age Groups (Pediatrics & Adults)
- Only Varicella Vaccine with 3 Years Shelf Life
- Free from Cancer & Allergy causing agents like MSG & Gelatin.
- Superior Vaccine with Maximum Effectiveness (91.4%)
- 10 Million Doses Successfully Administered by Indian Paediatricians
